Invesco S&P SmallCap Health Care ETF (PSCH)
NASDAQ: PSCH · Real-Time Price · USD
53.06
+0.15 (0.28%)
Jul 28, 2026, 10:51 AM EDT - Market open
0.28% (1D)
| Assets | $161.68M |
| Expense Ratio | 0.29% |
| PE Ratio | 29.97 |
| Shares Out | 3.07M |
| Dividend (ttm) | $0.00 |
| Dividend Yield | 0.01% |
| Ex-Dividend Date | Mar 23, 2026 |
| Payout Frequency | Semi-Annual |
| Payout Ratio | 0.28% |
| Volume | 3,065 |
| Open | 53.20 |
| Previous Close | 52.91 |
| Day's Range | 53.06 - 53.65 |
| 52-Week Low | 37.45 |
| 52-Week High | 54.62 |
| Beta | 0.83 |
| Holdings | 74 |
| Inception Date | Apr 7, 2010 |
About PSCH
Fund Home PageThe Invesco S&P SmallCap Health Care ETF (PSCH) is an exchange-traded fund that is based on the S&P SmallCap 600 Capped Health Care index, a market-cap-weighted index of small-cap health care companies taken from the S&P SmallCap 600 Index. PSCH was launched on Apr 7, 2010 and is issued by Invesco.
Asset Class Equity
Category Health
Stock Exchange NASDAQ
Ticker Symbol PSCH
ETF Provider Invesco
Index Tracked S&P SmallCap 600 Capped Health Care Index
Top 10 Holdings
37.49% of assets| Name | Symbol | Weight |
|---|---|---|
| Corcept Therapeutics Incorporated | CORT | 4.76% |
| Glaukos Corporation | GKOS | 4.71% |
| Alkermes plc | ALKS | 4.60% |
| Protagonist Therapeutics, Inc. | PTGX | 4.30% |
| TG Therapeutics, Inc. | TGTX | 3.86% |
| PTC Therapeutics, Inc. | PTCT | 3.33% |
| Liquidia Corporation | LQDA | 3.16% |
| Ligand Pharmaceuticals Incorporated | LGND | 3.15% |
| Teleflex Incorporated | TFX | 3.05% |
| Indivior Pharmaceuticals, Inc. | INDV | 2.58% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 23, 2026 | $0.00033 | Mar 27, 2026 |
| Sep 22, 2025 | $0.00259 | Sep 26, 2025 |
| Jun 23, 2025 | $0.00199 | Jun 27, 2025 |
| Mar 24, 2025 | $0.01419 | Mar 28, 2025 |
| Dec 23, 2024 | $0.01801 | Dec 27, 2024 |
| Jun 24, 2024 | $0.06593 | Jun 28, 2024 |
Performance
PSCH had a total return of 36.15% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.30%.
News
Here's why small caps are beating the S&P 500 this quarter
Small caps are joining in on the market rally. The Russell 2000 has bounced 56% since the March bottom, outpacing the S&P 500's 46% run over the same stretch.
Other symbols: PSCF
6 years ago - CNBC